January 25, 2012
A whistleblower suit unsealed in Maryland federal court on Friday claims a Forest Laboratories Inc. unit paid kickbacks to the main author of a federally funded antidepressant drug study so he would rig it in favor of the company's drug Celexa, in violation of the False Claims Act.